Cas:208519-37-3 2-Chloro-6-(hydroxymethyl)-4-iodo-3-pyridinol manufacturer & supplier

Chemical Name:2-Chloro-6-(hydroxymethyl)-4-iodo-3-pyridinol

CAS.NO:208519-37-3

Synonyms:2-Chloro-6-(hydroxymethyl)-4-iodo-3-pyridinol 6-Chloro-5-hydroxy-4-iodopyridine-2-methanol;2-Pyridinemethanol, 6-chloro-5-hydroxy-4-iodo-;ED-0058;2-chloro-6-(hydroxymethyl)-4-iodopyridin-3-ol;chlorohydroxymethyliodopyridinol;2-Chloro-6-(hydroxymethyl)-4-iodo-3-pyridinol;6-chloro-5-hydroxy-4-iodo-2-pyridinemethanol

Molecular Formula:C₆H₅ClINO₂

Molecular Weight:285.467

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:390.0±42.0 °C at 760 mmHg

Density:2.2±0.1 g/cm3

Index of Refraction:1.712

PSA:53.35000

Exact Mass:284.905334

LogP:0.70

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 2-Chloro-6-(hydroxymethyl)-4-iodo-3-pyridinol 6-Chloro-5-hydroxy-4-iodopyridine-2-methanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-chloro-5-hydroxy-4-iodo-2-pyridinemethanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-chloro-5-hydroxy-4-iodo-2-pyridinemethanol Use and application,ED-0058 technical grade,usp/ep/jp grade.

Related News: In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. 2-Chloro-6-(hydroxymethyl)-4-iodo-3-pyridinol manufacturer In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. 2-Chloro-6-(hydroxymethyl)-4-iodo-3-pyridinol supplier The researchers also found that Black women are much less likely to undergo genetic counseling and testing, largely due to differences in physician recommendations or access to care. 2-Chloro-6-(hydroxymethyl)-4-iodo-3-pyridinol vendor Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday. 2-Chloro-6-(hydroxymethyl)-4-iodo-3-pyridinol factory Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.